Diane Macabrey

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


6 publications

2023 | 2022 | 2019 |
 
Clinical Potential of Hydrogen Sulfide in Peripheral Arterial Disease.
Bechelli C., Macabrey D., Deglise S., Allagnat F., 2023/06/09. International journal of molecular sciences, 24 (12) p. 9955. Peer-reviewed.
Cystathionine-γ-lyase overexpression modulates oxidized nicotinamide adenine dinucleotide biosynthesis and enhances neovascularization.
Kiesworo K., MacArthur M.R., Kip P., Agius T., Macabrey D., Lambelet M., Hamard L., Ozaki C.K., Mitchell J.R., Déglise S. et al., 2023. JVS-vascular science, 4 p. 100095. Peer-reviewed.
 
Hydrogen Sulphide Release via the Angiotensin Converting Enzyme Inhibitor Zofenopril Prevents Intimal Hyperplasia in Human Vein Segments and in a Mouse Model of Carotid Artery Stenosis.
Macabrey D., Deslarzes-Dubuis C., Longchamp A., Lambelet M., Ozaki C.K., Corpataux J.M., Allagnat F., Déglise S., 2022/02. European journal of vascular and endovascular surgery, 63 (2) pp. 336-346. Peer-reviewed.
Clinical Use of Hydrogen Sulfide to Protect Against Intimal Hyperplasia.
Macabrey D., Longchamp A., Déglise S., Allagnat F., 2022. Frontiers in cardiovascular medicine, 9 p. 876639. Peer-reviewed.
 
Sodium thiosulfate, a source of hydrogen sulfide, stimulates endothelial cell proliferation and neovascularization.
Macabrey D., Joniová J., Gasser Q., Bechelli C., Longchamp A., Urfer S., Lambelet M., Fu C.Y., Schwarz G., Wagnières G. et al., 2022. Frontiers in cardiovascular medicine, 9 p. 965965. Peer-reviewed.
 
Hydrogen sulfide-releasing peptide hydrogel limits the development of intimal hyperplasia in human vein segments.
Longchamp A., Kaur K., Macabrey D., Dubuis C., Corpataux J.M., Déglise S., Matson J.B., Allagnat F., 2019/10/01. Acta biomaterialia, 97 pp. 374-384. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University